ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
33 hedge funds and large institutions have $5.25M invested in Acura Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $8.96M → $5.25M (-$3.71M)
Holders
33
Holding in Top 10
1
Calls
$6K
Puts
–
Top Buyers
| 1 | +$45K | |
| 2 | +$20.9K | |
| 3 | +$10K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$8.52K |
| 5 |
Goldman Sachs
New York
|
+$8.16K |
Top Sellers
| 1 | -$12.3K | |
| 2 | -$10.6K | |
| 3 | -$8.12K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.46K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |